The Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical Trial
- PMID: 38826182
- PMCID: PMC11140252
- DOI: 10.12997/jla.2024.13.2.89
The Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical Trial
Erratum in
- 
  
  Corrigendum to Previously Published Articles.J Lipid Atheroscler. 2025 Jan;14(1):132-133. doi: 10.12997/jla.2025.14.1.132. Epub 2025 Jan 14. J Lipid Atheroscler. 2025. PMID: 39911960 Free PMC article.
Abstract
The effect of omega-3 supplementation on cardiovascular (CV) disease has been widely studied in several large clinical trials. However, the evidence of the effect of omega-3 supplementation in patients with heart failure (HF) remains controversial. This meta-analysis investigated the effects of omega-3 supplementation on patients with HF. We conducted a literature search on MEDLINE, Embase, and Cochrane databases for clinical trials and preprints of relevant articles. Following a literature search and critical appraisal, 5 studies were included in the meta-analysis. The pooling of the result of the studies shows that there were no significant association between omega-3 supplementation and CV mortality (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.84-1.05, p=0.16) nor hospitalization due to HF (OR, 0.94; 95% CI, 0.88-1.02; p=0.13). Our systematic review and meta-analysis showed that omega-3 supplementation has no beneficial effect in patients with HF.
Keywords: Atherosclerosis; Cardiovascular disease; Omega-3 fatty acid; Secondary prevention.
© 2024 The Korean Society of Lipid and Atherosclerosis.
Conflict of interest statement
Conflict of Interest: The authors have no conflicts of interest to declare.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - O’Keefe JH, Jr, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc. 2000;75:607–614. - PubMed
 
- 
    - Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11–22. - PubMed
 
- 
    - Risk and Prevention Study Collaborative Group. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med. 2013;368:1800–1808. - PubMed
 
- 
    - Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant. 2006;25:834–838. - PubMed
 
Publication types
LinkOut - more resources
- Full Text Sources
- Research Materials
- Miscellaneous
 
        